Arcutis Biotherapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
Arcutis Biotherapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
Arcutis Biotherapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.